作者:
Cesne,A.L. [1]
;
Judson,I. [2]
;
Maki,R. [3]
;
Grosso,F. [4]
;
Schuetze,S. [5]
;
Mehren,M.V. [6]
;
Chawla,S.P. [7]
;
Demetri,G.D. [8]
;
Nieto,A. [9]
;
Tanovic,A. [10]
;
Blay,J.-Y. [11]
作者单位:
Division of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Fulham Road, London SW3
[1]
Division of Hematology/Oncology, Department of Medicine, University of Michigan, 1500 East Medical
[2]
Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111
[3]
Clinical Development, PharmaMar, Avenida de los Reyes 1, PI La-Mina-Norte, 28770 Colmenar Viejo
[4]
Department of Medicine, Institut Gustave Roussy, 39/53 rue Camille Desmoulins, FR-94805 Villejuif
[5]
Department of Cancer Medicine, Adult Sarcoma Medical Treatment Unit, IRCCS Foundation-National
[6]
Department of Medicine, Centre Leon Berard, 28 Rue Laennec, 69008 Lyon, France
[7]
Department of Medicine and Paediatrics, Mount Sinai Hospital NY, New York, NY 10029, United States
[8]
Ludwig Center, Dana-Farber Cancer Institute, Harvard Cancer and Sarcoma Center, 44 Binney Street
[9]
Medical Affairs, PharmaMar, Parc Cientific de Barcelona, Baldiri i Reixac 4-6, 08028 Barcelona
[10]
Department of Medical Oncology, Sarcoma Oncology Center, 2811 Wilshire Boulevard, Santa Monica, CA
[11]
发布时间
2014-01-21